耐性菌感染症の克服に向けた薬剤排出ポンプの構造解析と新規治療薬開発

DOI Web Site Web Site PubMed 参考文献9件 オープンアクセス

書誌事項

タイトル別名
  • Structural Analysis and New Drug Development against Multidrug Efflux Pumps
  • Symposium Review 耐性菌感染症の克服に向けた薬剤排出ポンプの構造解析と新規治療薬開発
  • Symposium Review タイセイキン カンセンショウ ノ コクフク ニ ムケタ ヤクザイ ハイシュツ ポンプ ノ コウゾウ カイセキ ト シンキ チリョウヤク カイハツ

この論文をさがす

抄録

 Multidrug efflux pumps are important in the multidrug resistance of Gram-negative pathogens. However, despite efforts to develop efflux inhibitors, clinically useful inhibitors are not available at present. ABI-PP (a pryridopyrimidine derivative) is a MexB-specific inhibitor that does not inhibit MexY; MexB and MexY are principal pumps in Pseudomonas aeruginosa. We previously found that drugs were exported through tandem proximal and distal multisite drug-binding pockets. Here we describe the first inhibitor-bound structures of pumps. ABI-PP binds tightly to a narrow pit located in the distal pocket and sterically hinders the functional rotation. Phenylalanine is located at the edge of this pit in MexB and contributes to the tight binding of the inhibitor molecule. On the other hand, the voluminous side chain of tryptophan located at the corresponding position in MexY prevents inhibitor binding. For the development of universal inhibitors of MexB and MexY, it is important to avoid the steric hindrance of tryptophan in MexY. Now we are developing clinically useful inhibitors on the basis of the structural information obtained. Started from the ABI-PP structure, we designed many compounds that can bind to the inhibitor-binding pits of MexB and MexY. Some of designed compounds were actually synthesized and their inhibitory activity determined. Finally, we obtained some lead compounds that showed complete prevention of the growth of strains expressing MexB and MexY with low concentrations of antibiotics.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 137 (4), 377-382, 2017-04-01

    公益社団法人 日本薬学会

参考文献 (9)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ